96494 ⎘
Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
Sub-classes:DHCR24 INHIBITORY COMPOUNDS
#2PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS
#3Processes for the preparation of ortho-allylated hydroxy aryl compounds
#4STEROL ANALOGS AND USES THEREOF
#5ANTAGONISTS OF CB1 RECEPTOR
#6CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL
#7Processes for the preparation of -allylated hydroxy aryl compounds
#8Crystalline solvate forms of a pharmaceutical
#9ANTAGONISTS OF CB1 RECEPTOR
#10Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
#11Base-catalyzed silylation of terminal alkyne C—H bonds
#12NEUROACTIVE 13, 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS
#13Compositions and methods for inhibiting norovirus infection
#14Treatment methods using pharmaceutical solid state forms
#15Antagonists of CB1 receptor
#16Crystalline anhydrate forms of a pharmaceutical
#17Base-catalyzed silylation of terminal alkyne C—H bonds
#18Treatment methods using pharmaceutical solid state forms
#19NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION
#20Compositions and methods for inhibiting norovirus infection
#21Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
#22Antagonists of CB1 receptor
#23Methods of preparing pharmaceutical solid state forms
#24PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF
#25ANTISOLVENT SOLIDIFICATION PROCESS
#26TREATMENT METHODS USING PHARMACEUTICAL SOLID STATE FORMS
#27CRYSTALLINE ANHYDRATE FORMS OF A PHARMACEUTICAL
#28ANTISOLVENT SOLIDIFICATION PROCESS
#29ANTISOLVENT SOLIDIFICATION PROCESS
#30Guggulphospholipid methods and compositions
#31Solid state forms of a pharmaceutical
#32Pharmaceutical solid state forms
#33COMPOUND
#34Antisolvent solidification process